382 related articles for article (PubMed ID: 34024444)
21.
Maslennikov R; Ivashkin V; Ufimtseva A; Poluektova E; Ulyanin A
Future Microbiol; 2022 Jun; 17():653-663. PubMed ID: 35440149
[TBL] [Abstract][Full Text] [Related]
22. Clostridioides difficile infection in Africa: A narrative review.
Kullin B; Abratt VR; Reid SJ; Riley TV
Anaerobe; 2022 Apr; 74():102549. PubMed ID: 35337974
[TBL] [Abstract][Full Text] [Related]
23. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.
Zhou FF; Wu S; Klena JD; Huang HH
Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1773-9. PubMed ID: 24820293
[TBL] [Abstract][Full Text] [Related]
25. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
Adams DJ; Barone JB; Nylund CM
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
[TBL] [Abstract][Full Text] [Related]
26. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
[TBL] [Abstract][Full Text] [Related]
27. Recent development of small-molecular inhibitors against Clostridioides difficile infection.
Chen J; Lu Y; Du Y; Wang H; Wu Q
Bioorg Chem; 2022 Aug; 125():105843. PubMed ID: 35561529
[TBL] [Abstract][Full Text] [Related]
28. Anti-virulence strategies for
Stewart D; Anwar F; Vedantam G
Gut Microbes; 2020 Nov; 12(1):1802865. PubMed ID: 33092487
[No Abstract] [Full Text] [Related]
29. Diagnosis and management of paediatric Clostridioides difficile infection in a tertiary centre: A prospective audit.
Gates V; Best E; Roberts S; Swager T; Voss L
J Paediatr Child Health; 2021 Apr; 57(4):500-506. PubMed ID: 33145899
[TBL] [Abstract][Full Text] [Related]
30. Toxic Clostridioides (formerly Clostridium) difficile colitis: No longer a diarrhea associated infection.
Nwachuku E; Shan Y; Senthil-Kumar P; Braun T; Shadis R; Kirton O; Vu TQ
Am J Surg; 2021 Jan; 221(1):240-242. PubMed ID: 32680621
[TBL] [Abstract][Full Text] [Related]
31. Molecular Epidemiology of Clostridioides difficile Infections in Children.
Perumalsamy S; Riley TV
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S34-S40. PubMed ID: 34791401
[TBL] [Abstract][Full Text] [Related]
32. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
[No Abstract] [Full Text] [Related]
33. Vaccines against Clostridium difficile.
Leuzzi R; Adamo R; Scarselli M
Hum Vaccin Immunother; 2014; 10(6):1466-77. PubMed ID: 24637887
[TBL] [Abstract][Full Text] [Related]
34. Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.
Kovačević N; Lendak D; Popović M; Plećaš Đuric A; Pete M; Petrić V; Sević S; Tomić S; Alargić J; Damjanov D; Kosjer D; Lekin M
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143939
[No Abstract] [Full Text] [Related]
35. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
36. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
37. [Interpretation of group standard for
Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
[TBL] [Abstract][Full Text] [Related]
38. Current Diagnostic and Treatment Approach of Clostridioides difficile Infection.
Yunita B; Fauzi A
Acta Med Indones; 2023 Apr; 55(2):231-238. PubMed ID: 37524596
[TBL] [Abstract][Full Text] [Related]
39. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
Sattler MM; Crews JD
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
[TBL] [Abstract][Full Text] [Related]
40. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
